Author: Jia-Horng Kao (Editor) Full Title: Hepatitis B Virus And Liver Disease, 2nd Edition Publisher: Springer; 2nd ed. 2021 edition (August 24, 2021) Year: 2021 ISBN-13: 9789811636158 (978-981-16-3615-8), 9789811636141 (978-981-16-3614-1), 9789811636172 (978-981-16-3617-2) ISBN-10: 981163615X, 9811636141, 9811636176 Pages: 508 Language: English Genre: Medicine: Internal Medicine File type: EPUB (True), PDF (True) Quality: 10/10 Price: 192.59 € This book provides a comprehensive, state-of-the art review of HBV infection and liver disease. It discusses new data on basic and translational medicine, including the viral life cycle, the immunopathogenesis of virus-induced chronic hepatitis, viral and host genetic factors affecting disease progression, and the mechanism of virus-induced hepatocarcinogenesis, as well as their potential applications in daily clinical practice. The clinical aspects of chronic HBV infection are examined in chapters on the global epidemiology, efficacy of HBV vaccination, natural history, novel biomarkers, co-infections with HCV, HDV or HIV, and management of special populations including children, pregnant women and patients undergoing immunosuppressive therapy. Further, it describes the advances and perspectives in the development of novel antiviral treatments for possible functional cure of HBV infection. In this second edition, authors provides recent updates in epidemiology, biomarkers, antivirus therapy, and novel therapy for functional cure of chronic hepatitis B virus infection. The book is a valuable resource for medical students, physicians, and researchers who are interested in management of patients with chronic HBV infection and investigation HBV infection. Overview: ✓ Provides a comprehensive summary of the advances in patient management to stimulate further research ✓ Discusses the latest clinical and scientific information ✓ Includes recent achievement in diagnosis and treatment ✓ Serves as a valuable resource for medical students, physicians and researchers dealing with, and interested in, this challenging viral infection ------------- Our members see more. Join us!